Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation? No, writes Yale cardiologist Harlan Krumholz.

Thetoday reported on the most serious infectious risks facing the blood supply: bacterial contamination of donated platelets. In its article, titled “The Biggest Blood Supply Risk: Tainted Platelets,” ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

LAKE ZURICH, Ill. & WORCESTER, Mass.--(BUSINESS WIRE)--A $30 test that takes fewer than 30 minutes to perform can prevent potentially deadly transfusions of bacterial contamination in platelets, ...

San Diego medical diagnostics company Accumetrics said Wednesday that its test for measuring the effectiveness of anti-blood clotting medicines will be used in clinical trials of an experimental drug ...

LOS ANGELES, CA—In patients with acute coronary syndromes (ACS) treated with prasugrel, the incidence of high on-treatment platelet reactivity depends on the type of platelet function test used, ...

A blood-based platelet RNA test that uses the equivalent of one drop of blood can identify patients with cancer, differentiate between cancer types, and even pick out mutant biomarkers, say European ...

WASHINGTON, Sept. 18 (UPI) -- The U.S. Food and Drug Administration has approved for marketing the first pretransfusion rapid blood platelet bacterial contamination test. The Platelet Pan Genera ...

It is easy to use—A tube of blood is inserted and the result is automatically displayed within 10 minutes, making it the first test suitable to use in a clinical setting, even in the cath lab. It is ...

The fundamental role of platelets in haemostasis and thrombosis relies on their capability of adhesion to specific locations of the perturbed vessel wall upon injury, damage or inflammation. Continued ...

The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.